Literature DB >> 10982812

Release of the neocarzinostatin chromophore from the holoprotein does not require major conformational change of the tertiary and secondary structures induced by trifluoroethanol.

G C Sudhahar, K Balamurugan, D H Chin.   

Abstract

Neocarzinostatin is a potent enediyne antitumor antibiotic complex in which a chromophore is noncovalently bound to a carrier protein. The protein regulates availability of the drug by proper release of the biologically active chromophore. To understand the physiological mechanism of the drug delivery system, we have examined the trifluoroethanol (TFE)-induced conformational changes of the protein with special emphasis on their relation to the release of the chromophore from holoneocarzinostatin. The effect of the alpha helix-inducing agent, TFE, on all the beta-sheet neocarzinostatin proteins was studied by circular dichroism, fluorescence, and (1)H NMR studies. By using binding of anilinonaphthalene sulfonic acid as a probe, we observed that the protein exists in a stable, partially structured intermediate state around 45-50% TFE, which is consistent with the results from tryptophan fluorescence and circular dichroism studies. The native state is stable until 20% TFE and is half-converted into the intermediate state at 30% TFE, which starts to collapse beyond 50%. High pressure liquid chromatographic analysis of the release of the chromophore caused by TFE treatment at 0 degrees C suggests that the release process, which occurs below 20% TFE, does not result from an observable conformational change in the protein. Kinetic measurements of the release of chromophore at 25 degrees C reveal that TFE does stimulate the rate of release, which increases sharply at 15% and reaches a maximum at 20% TFE, although no major secondary or tertiary structural change of the carrier protein is observed under these same conditions. Our data suggest that chromophore release results from a fluctuation of the protein structure that is stimulated by TFE. Complete release of the chromophore occurs at TFE concentrations where no overall observable unfolding of the apoprotein is seen. Thus, the results suggest that denaturation of the protein by TFE is not a necessary step for release of the tightly bound chromophore.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982812     DOI: 10.1074/jbc.M006837200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Cold instability of aponeocarzinostatin and its stabilization by labile chromophore.

Authors:  Kandaswamy Jayachithra; Thallampuranam Krishnaswamy Suresh Kumar; Ta-Jung Lu; Chin Yu; Der-Hang Chin
Journal:  Biophys J       Date:  2005-04-08       Impact factor: 4.033

2.  Is association of labile enediyne chromophore a mutually assured protection for carrier protein?

Authors:  Jayachithra Kandaswamy; Parameswaran Hariharan; Thallapuranam Krishnaswamy Suresh Kumar; Chin Yu; Ta-Jung Lu; Der-Hang Chin
Journal:  Anal Biochem       Date:  2008-06-14       Impact factor: 3.365

3.  Affinity transfer by CDR grafting on a nonimmunoglobulin scaffold.

Authors:  Magali Nicaise; Marielle Valerio-Lepiniec; Philippe Minard; Michel Desmadril
Journal:  Protein Sci       Date:  2004-05-28       Impact factor: 6.725

4.  A superior drug carrier--aponeocarzinostatin in partially unfolded state fully protects the labile antitumor enediyne.

Authors:  Aranganathan Shanmuganathan; Thallapuranam Krishnaswamy Suresh Kumar; Chiy-Mey Huang; Chin Yu; Der-Hang Chin
Journal:  J Biomed Sci       Date:  2009-05-23       Impact factor: 8.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.